ArticleFrontiers in molecular biosciences2025

Mechanistic study of glutamine metabolic reprogramming driving non-small cell lung cancer progression via the FGF17-FGFR4 axis mediating epithelial-mesenchymal transition.

Qinghua Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.